Thrombophilia: Genetic polymorphisms and their association with retinal vascular occlusive disease

British Journal of Ophthalmology

Volumn 85, Issue 7, 2001, Pages 883-886

  Chak, M ^a   Wallace, G R ^a   Graham, E M ^a   Stanford, M R ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN; HOMOCYSTEINE; PROTHROMBIN;

BEHCET DISEASE; DNA POLYMORPHISM; GENE MUTATION; GENOTYPE; HUMAN; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RETINA BLOOD VESSEL OCCLUSION; REVIEW; THROMBOPHILIA; VEIN THROMBOSIS;

BEHCET SYNDROME; FACTOR V; HUMANS; HYPERHOMOCYSTEINEMIA; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMORPHISM, GENETIC; PROTHROMBIN; RETINAL VEIN OCCLUSION; RISK FACTORS; THROMBOPHILIA;

EID: 0034925207     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.85.7.883     Document Type: Review

References (66)

1. Activated protein C and retinal vein occlusion
2. Risk factors for venous thrombosis: Prevalence, risk and interaction
3. Risk factors for branch retinal vein occlusion
4. Risk factors for central retinal vein occlusion
5. Risk factors for hemiretinal vein occlusion: Comparison with risk factors for central and branch retinal vein occlusion
6. Central retinal vein occlusion in young adults
7. Risk factors for retinal vein occlusions
8. The risk for systemic vascular diseases and mortality in patients with central retinal vein occlusion
9. Role of rheologic factors in patients with acute central vein occlusions
10. Elevated erythrocyte aggregration in patients with central retinal vein occlusion and without conventional risk factors
11. Hereditable thrombophilia and hypofibrinolysis
12. Hypercoagulability and high lipoprotein (a) levels in patients with central retinal vein occlusion
13. Retinal artery occlusion
14. Anterior ischaemic optic neuropathy: Trouble waiting to happen
15. Nonarteritic ischaemic neuropathy. A case control study of potential risk factors
16. Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischaemic optic neuropathy
17. Mutation in blood coagulation factor V associated with resistance to activated protein C
18. Thrombophilia
19. Screening for resistance to activated protein C and the mutant gene for factor V:Q506 in patients with central retinal vein occlusion
20. Central retinal vein thrombosis associated with resistance to activated protein C
21. Peripheral retinal neovascularisation and retinal vascular occlusion associated with activated protein C resistance
22. Bilateral retinal vein occlusion associated with factor V Leiden mutation
23. Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: A population controlled study
24. Activated protein C resistance in young adults with central retinal vein occlusion
25. Activated protein C resistance in patients with central retinal vein occlusion
26. Venous thrombosis - The interaction of genes and environment
27. The risk of recurrent deep vein thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation
28. High risk of cerebral vein thrombosis in carriers of a prothrombin gene mutation and in users of oral contraceptives
29. Retinal vascular occlusions and deficiencies in the protein C pathway
30. Retinal vascular occlusion and deficiencies in the protein C pathway
31. Retinal vein occlusion and inherited conditions predisposing to thrombophilia
32. The modified APC resistance test in the presence of factor V deficient plasma can be used in patients without oral anticoagulant
33. Activated protein C resistance, factor V Leiden, and central retinal vein occlusion in young adults
34. Prevalence of factor V Leiden in young adults with retinal vein occlusion
35. Factor V and antithrombin gene mutations in patients with idiopathic central retinal vein occlusion
36. Activated protein C resistance - Low incidence in glaucomatous optic disc haemorrhage and central retinal vein occlusion
37. Analysis of genetic polymorphisms related to thrombosis and other risk factors in patients with retinal vascular occlusion
38. Factor V Leiden mutation is associated with ocular involvement in Behçet's disease
39. Factor V Leiden mutation in patients with Behçet's disease
40. Association of factor V Leiden with Behçet's disease
41. Retinal artery occlusion in a child with factor V Leiden and thermolabile methylene tetrahydrofolate reductase mutations
42. Multiple retinal arteriolar occlusions associated with coexisting primary antiphospholipid syndrome and factor V Leiden mutation
43. Branch retinal vein occlusion associated with familial factor V Leiden polymorphism and positive rheumatoid factor
44. Arterial vascular occlusion associated with factor V Leiden gene mutation
45. Anterior ischaemic optic neuropathy and activated protein C resistance. A case report and review of the literature
46. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
47. Geographic distribution of the 20210 G to A prothrombin variant
48. Idiopathic central retinal vein occlusion in a thrombophilic patient with the heterozygous 20210 G/A prothrombin genotype
49. Familial thrombophilia and retinal vein occlusion
50. Hyperhomocysteinaemia and atherosclerotic disease
51. Hyperhomocystinemia in retinal artery and retinal vein occlusion
52. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
53. Incidence of various types of retinal vein occlusions and their recurrence and demographic characteristics
54. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the existence of the FV Leiden and the prothrombin A[20210] mutation
55. The mutation Aa1677 toVal in the methylene tetrahydrofolate reductase gene: A risk factor for arterial disease and venous thrombosis
56. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep vein thrombosis
57. Retinal vein occlusion associated with methylenetetrahydrofolate reductase mutation
58. A bilateral retinal vein occlusion associated with 5,10-methylenetetrahydrofolate
59. Hyperhomocysteinaemia and the MTHFR 677T mutation in central retinal vein occlusion
60. Thermolabile MTHFR genotype and retinal vascular occlusive disease
61. Hyperhomocysteinaemia in patients with nonarteritic anterior ischaemic optic neuropathy, central retinal artery occlusion and central retinal vein occlusion
62. Hyperhomocystenaemia in patients with nonarteritic ischaemic anterior optic neuropathy
63. Is non-arteritic anterior ischaemic optic neuropathy related to homocysteine?
64. Homocysteine - A novel risk factor for vascular disease
65. Preventing coronary heart disease: B vitamins and homocysteine
66. Inherited thrombophilia: Part 1